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Abstract
Background: Charcot neuroarthopathy (CN), a rare foot and ankle condition usually complicating diabetes mellitus,
leads to deformity, poor quality of life, and increased mortality and morbidity. The prevalence of this condition in
the diabetic patient population is not currently known but has been reportedly misdiagnosed in up to 95% of
cases.
Methods: We sought to evaluate general knowledge regarding CN in non-foot specialist clinical faculty at a large
academic institution and to understand their practice habits. Our survey emphasizes the necessity of better
education surrounding CN to improve outcomes in a preventative fashion. This will enable us to determine how to
focus educational forums surrounding this topic in the future.
Results: Seven hundred eighty-nine faculty members were sent the survey while 400 completed the survey for a
response rate of 50.7%. The respondents were representative of academic rank at the institution and were comprised
of endocrinologists, internal medicine physicians and family medicine physicians. We found that 67.6% of responders
had a self-described poor or complete lack of knowledge of this condition. Clinicians with self-described better
knowledge of CN were more likely to provide a correct initial management of CN (p < 0.001; r = 0.3639).
Conclusions: In this large tertiary institution, a majority of providers among internal medicine, endocrinologists, and
family medicine physicians demonstrated minimal or no knowledge of this rare, but potentially devastating diabetes
complication. However, those providers who are knowledgeable of CN, performed better in the initial management of
this condition. Also, respondents who treated more diabetic patients demonstrated an association with correct
management. Education, and the development of better understanding amongst clinicians, is crucial to limit the
devastating effects of this condition in the future.
Background
Charcot neuroarthopathy (CN), is a rare foot and ankle con-
dition [1] that can lead to both structural and functional ab-
normalities resulting in ulceration and amputation. CN has
an overall incidence of 0.1% - 0.9% and it is more commonly
thought to be seen, relatively, in the diabetic population [2–
5]. However, since there is not an unambiguous definition
or diagnosis for CN, true incidence and prevalence data is
not currently known [1]. Past studies have demonstrated
that referring physicians can misdiagnosis CN up to 95% of
the time when referring to a foot specialist [6–8]. When an
accurate diagnosis is made and treated within 8 weeks of
onset, there is a five-fold reduction in complications
from 67% to 14% [6]. It has been estimated that the
average diagnostic delay is up to 29 weeks [9]. More as-
tute recognition of CN is critical given both the rarity of
this condition and rapid escalation in foot collapse excess
morbidity experienced by these patients following mis-
diagnosis or delayed diagnosis [2–4, 6].
There is a lack of literature about general knowledge
of CN amongst physicians. A search in PubMed/NCBI,
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Google Scholar, and Cochrane Databases for Charcot
foot education in physician reveals no studies on the
specific subject. Therefore, the objective of this study
was to evaluate general CN knowledge in the diagnosis
and initial management among non-foot specialist clini-
cians in a large academic based-practice.
Methods
A fourteen item questionnaire was developed (Additional
file 1) with an online tool (Qualtrics, www.qualtrics.com).
Questions were formulated to better understand clinical
knowledge of CN in relation to differential diagnosis, im-
aging, diagnosis and classification, clinical tests, and man-
agement. There were also questions regarding experience
and training. The questionnaire was designed to only take
3 min or less to complete and was sent to all internal
medicine clinical faculty members and family medicine at
the University Health System. All responses were an-
onymous and respondents could only take the survey
once. The only identifying condition of the survey re-
sponse was the IP address of the computer or mobile de-
vice where it was accessed. Qualtrics reports information
about the e-mail itself, such as: if it was opened, when the
survey was started, when the survey was completed, the
time it took the respondent to complete the survey, and if
the survey was completed or only partially completed.
The local institutional review board approved the study.
Analyses
We excluded all partially completed surveys. Statistical
analysis consisted evaluation of trends between and
among groups. The Pearson correlation coefficient was
used to quantify correlation, if any, between queried rela-
tionships. All statistical analysis was completed using SPSS
statistical software, version 22 (SPSS Inc., Chicago, IL).
Statistical significance was set at the 5% level (p ≤ 0.05).
Results
The survey was sent to 789 clinical faculty members.
Qualtrics reported a delivery of 100% of the survey to the
desired e-mail locations. 448 surveys were started and 400
surveys were completed (89.3%). Non-responders did not
attempt survey. The overall response rate was 50.7%.
Forty-eight surveys were only partially completed and
each of them was less than 50% complete. The data from
these incomplete surveys were excluded from analysis.
For medical specialty, there were 56.9% internal medi-
cine, 17.2% family medicine, 12.1% endocrinologists, 5.9%
rheumatologists, and the remaining 6.9% responded as
other, including pulmonary, palliative medicine, oncology,
plastic surgery, and infectious disease. Academic rank of
those completing the survey, included: 3.2% fellows, 9.6%
clinical lecturer, 10.3% clinical instructor, 44.1% assistant
professor, 16.2% associate professor, and 16.7% were at the
professor level. There were no disparate responses
amongst rank when compared to medical school data.
When we asked the individuals responding to the sur-
vey to describe their knowledge of CN only 6.9% re-
ported having excellent knowledge while 5.0% reported
as good, and 20.5% reported fair, while the remaining
67.6% reported having a poor or no knowledge of CN.
Academic rank demonstrated a significant association
(p < 0.05; p = 0.0422) with self-described CN know-
ledge although correlation was weak (r = 0.1070). Spe-
cialty did not demonstrate a significant association
with CN knowledge (p > 0.05; r = 0.1228).
We inquired about diabetes patient panel size. We re-
ceived 375 responses. 49.1% (n = 184) selected 0-25%,
36.5% (n = 137) selected 25-50%, 8.0% (n = 30) choose
50-75%, and 3.7% (n = 14) selected 75-100% of patients
having diabetes mellitus. There was no significant associ-
ation between rank and/or specialty reported with per-
centage of diabetic patients seen.
Of the 44 who chose greater than 51% (majority) treat
persons with diabetes in their clinics, the vast majority
of these physicians (n = 37, 84.1%) choose offloading as
treatment for a patient with CN while the remaining 7
choose referral (15.9%). This is in contrast to physicians
who treat less than 50% of people with diabetes in their
clinic. Of the 317 who answered in this way, 156 (49.2%)
chose offloading, 143 (45.1%) choose referral, and 18
(5.7%) chose no treatment. However, significant differ-
ence between these groups was not realized (p > 0.05).
We found a significant inverse relationships between
percent patients with diabetes patients seen and self-re-
ported knowledge of CN (p < 0.001, r = −0.3149) and un-
derstanding that peripheral neuropathy is required for a
CN event (p < 0.001, r = −0.1962). Providers seeing more
diabetes patients were significantly more likely to select
offloading as treatment modality of choice (p = 0.0014,
r = −0.2307). The association was independent of self-
assessed CN knowledge (p < 0.001; r =0.3639).
Discussion
Charcot neuroarthopathy is often misdiagnosed [6–8]
which can lead to severe sequelae including limited mo-
bility, ulceration, infection, amputation, decreased qual-
ity of life, and increased mortality [10, 11]. Previous CN
intervention has been done in later stages with costs
ranging from $49,251 to $56,712 for major lower ex-
tremity amputation versus reconstructive limb salvage,
respectively [12]. Despite advances in limb salvage in-
cluding surgery we still see devastating effects. This
may be the result of lack of recognition of the condi-
tion entirely.
We feel that a better target is physician education and
prevention of the debilitating limb threatening deformities.
We sought to evaluate CN knowledge of non-foot specialist
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providers at a large academic institution to identify gaps in
knowledge in preparation for future clinician related educa-
tion programs. The sample included diversity in physician
rank and practice including: internal medicine, family medi-
cine, rheumatologists, endocrinologists, among others.
Not surprisingly, we found that most survey respondents,
approximately 67.6%, had a poor or no general self-
described knowledge of CN. Frequently, early changes of
CN are not recognized by the patient as they are neuro-
pathic. Upon initial evaluation as there are no gross foot de-
formities by exam or x-ray, and subtle joint temperature
increases (~9 °F) [13] cannot be appreciated by many clini-
cians. When referrals delays are factored in, it is not sur-
prising that many CN patients experience excess morbidity
and mortality [14].
Self-described knowledge of CN was associated with
correct initial management (p < 0.001; r = 0.3639) of off-
loading. We thought that physicians who saw more dia-
betic patients would also correctly treat a patient with CN,
as it is a complication in this population. This was largely
confirmed by analyzing groups who see a majority of dia-
betic patients in their clinic versus those who do not al-
though our findings did not reach statistical significance.
Nevertheless, we attribute this to weak powering in the
group of physicians who see majority diabetic patients in
their clinics. Subsequently, we did demonstrate that there
is a significant trend between percent people with diabetes
and correctly managing a patient with CN.
Conclusion
CN is a disease which afflicts patients with small fiber per-
ipheral neuropathy. If not appropriately diagnosed and
treated quickly, the consequences can be significant and lead
to increased patient morbidity and mortality. In our survey,
we identified most respondents from a large academic insti-
tution do not have a self-described general knowledge of
CN and this may further lead to the practitioners (in-) abil-
ity to correctly diagnose CN. Furthermore, we demon-
strate that the better one’s knowledge is of CN, the more
apt that physician is to correctly treat the condition ini-
tially with offloading. Also, larger diabetes panel sizes
demonstrated an association with managing this subset of
patients correctly. Our study highlights the importance of
education and demonstrates the need for more educa-
tional and awareness programs for referring providers
about CN as well as more efficient referral processes.
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